Inventory/Unearned Revenue From Related Party (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2019 |
Mar. 31, 2019 |
Jun. 30, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Dec. 31, 2018 |
|
Payment for purchase of inventory | $ 16,700,000 | $ 3,300,000 | ||||
Proceeds from sale of inventory | $ 28,000,000 | |||||
Billed amount | 25,672,676 | $ 2,937,325 | 29,188,492 | $ 5,020,275 | ||
Accounts receivable from related party | 25,177,845 | 25,177,845 | ||||
Revenues from related party | 22,014,878 | 22,014,878 | ||||
Gross profit | 8,927,123 | $ 2,023,968 | 11,188,149 | $ 3,218,049 | ||
Gen Canna [Member] | ||||||
Proceeds from sale of inventory | $ 18,000,000 | |||||
Billed amount, description | The seeds are to be harvested by October 2019, and accordingly the Company provided GenCanna with extended payment terms, allowing full payments to be made by December 2019. | |||||
Costs associated with unearned revenue | 15,700,000 | $ 15,700,000 | ||||
Unearned revenue | 3,200,000 | 3,200,000 | ||||
Accounts receivable from related party | $ 25,200,000 | 25,200,000 | ||||
Revenues from related party | 22,000,000 | |||||
Gen Canna [Member] | Billed Revenues [Member] | ||||||
Proceeds from sale of inventory | 15,700,000 | |||||
Billed amount | 25,200,000 | |||||
MariMed Hemp Inc. [Member] | ||||||
Payment for purchase of inventory | 20,000,000 | |||||
MediTaurus [Member] | Hemp Seeds [Member] | ||||||
Payment for purchase of inventory | 4,300,000 | |||||
MediTaurus [Member] | Hemp Oil [Member] | ||||||
Payment for purchase of inventory | $ 520,000 |
X | ||||||||||
- Definition Payment for purchase of inventory. No definition available.
|
X | ||||||||||
- Definition Proceeds from sale of inventory. No definition available.
|
X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of payment terms in contract with customer. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|